The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Long‐term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta‐analysis
Abstract
Objective: Although early initiation of disease‐modifying antirheumatic drugs (DMARDs) is effective in controlling short‐term joint damage in individuals with rheumatoid arthritis (RA), the long‐term benefit in disease progression is still controversial. We examined the long‐term benefit of early DMARD initiation on radiographic progression in early RA. Methods: We identified published and unpublished clinical trials and observational studies from 1966 to September 2004 examining the association between delay to treatment initiation and progressive radiographic joint damage. We included studies of persons with RA disease duration <2 years and DMARD therapy of similar efficacy during followup. The differences in annual rates of radiographic progression between early and delayed therapy were pooled as standardized mean differences (SMDs). Results: A total of 12 studies met the inclusion criteria. The pooled estimate of effects from these studies demonstrated a significant reduction of radiographic progression in patients treated early (−0.19 SMD, 95% confidence interval [95% CI] −0.34, −0.04), which corresponded to a −33% reduction (95% CI −50, −16) in long‐term progression rates compared with patients treated later. Patients with more aggressive disease seemed to benefit most from early DMARD initiation (P = 0.04). Conclusion: These results support the existence of a critical period to initiate antirheumatic therapy, a therapeutic window of opportunity early in the course of RA associated with sustained benefit in radiographic progression for up to 5 years. Prompt initiation of antirheumatic therapy in persons with RA may alter the long‐term course of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Self-citationOperating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
Variance imputation for overviews of clinical trials with continuous response
Follmann, D., Elliott, P., Suh, I., & Cutler, J. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90054-q · Cited by 1,385
Systematic Reviews in Health Care. Meta-analysis in Context.
Kleijnen, J., & Antes, G. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.3.697 · Cited by 1,363
Guidelines for the management of rheumatoid arthritis: 2002 Update
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) · Arthritis & Rheumatism · doi:10.1002/art.10148 · Cited by 1,185
St. Clair, E. W., van der Heijde, D. M. F. M., Smolen, J. S., Maini, R. N., Bathon, J. M., Emery, P., Keystone, E., Schiff, M., Kalden, J. R., Wang, B., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20568 · Cited by 1,143
Guidelines for the management of rheumatoid arthritis: 2002 Update
Yood, R. A. (2002) · Cited by 1,090
Möttönen, T., Hannonen, P., Leirisalo-Repo, M., Nissilä, M., Kautiainen, H., Korpela, M., Laasonen, L., Julkunen, H., Luukkainen, R., Vuori, K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08513-4 · Cited by 865
Guidelines for the Management of Rheumatoid Arthritis 2002 Update
Goolsby, M. J., & Newsome, G. (2002) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2002.tb00072.x · Cited by 855
Nell, V. P. K. (2004) · Rheumatology · doi:10.1093/rheumatology/keh199 · Cited by 818
Genovese, M. C., Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10308 · Cited by 733
Landewé, R. B. M., Boers, M., Verhoeven, A. C., Westhovens, R., van de Laar, M. A. F. J., Markusse, H. M., van Denderen, J. C., Westedt, M. L., Peeters, A. J., Dijkmans, B. A. C., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10083 · Cited by 612
Lard, L. R., Visser, H., Speyer, I., vander Horst-Bruinsma, I. E., Zwinderman, A. H., Breedveld, F. C., & Hazes, J. M. W. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00872-5 · Cited by 590
Epidemiology of rheumatic diseases
Sangha, O. (2000) · Rheumatology · doi:10.1093/rheumatology/39.suppl_2.3 · Cited by 575
(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration
Anderson, J. J., Wells, G., Verhoeven, A. C., & Felson, D. T. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<22::aid-anr4>3.0.co;2-9 · Cited by 503
Welsing, P. M. J., Van Gestel, A. M., Swinkels, H. L., Kiemeney, L. A. L. M., & Van Riel, P. L. C. M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9<2009::aid-art349>3.0.co;2-l · Cited by 498
van der Heide, A., Jacobs, J. W. G., Bijlsma, J. W. J., Heurkens, A. H. M., van Booma-Frankfort, C., van der Veen, M. J., Haanen, H. C. M., & Hofman, D. M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-8-199604150-00001 · Cited by 480
Felson, D. T., Anderson, J. J., Lange, M. L. M., Wells, G., & LaValley, M. P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9 · Cited by 474
EPIDEMIOLOGY OF RHEUMATIC DISEASES
(2006) · APLAR Journal of Rheumatology · doi:10.1111/j.1479-8077.2006.00199_10.x · Cited by 449
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Symmons, D. P. M., Jones, M., Scott, D. L., & Prior, P. (1998) · PubMed · Cited by 319
Egsmose, C., Lund, B., Borg, G., Pettersson, H., Berg, E., Brodin, U., & Trang, L. E. (1995) · PubMed · Cited by 312
Treating rheumatoid arthritis early: A window of opportunity?
O'Dell, J. R. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10092 · Cited by 266
Nuki, G., Bresnihan, B., Bear, M. B., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10578 · Cited by 222
The course of radiologic damage during the first six years of rheumatoid arthritis
Hulsmans, H. M. J., Jacobs, J. W. G., van der Heijde, D. M. F. M., van Albada-Kuipers, G. A., Schenk, Y., & Bijlsma, J. W. J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1927::aid-anr3>3.0.co;2-b · Cited by 219
Understanding the window of opportunity concept in early rheumatoid arthritis
Boers, M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11156 · Cited by 180
Puolakka, K., Kautiainen, H., Möttönen, T., Hannonen, P., Korpela, M., Julkunen, H., Luukkainen, R., Vuori, K., Paimela, L., Blåfield, H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11436 · Cited by 177
van der Heijde, D. M. F. M. (2000) · Rheumatology · doi:10.1093/oxfordjournals.rheumatology.a031496 · Cited by 171
Bukhari, M. A. S., Wiles, N. J., Lunt, M., Harrison, B. J., Scott, D. G. I., Symmons, D. P. M., & Silman, A. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10727 · Cited by 169
van Aken, J., Lard, L. R., le Cessie, S., Hazes, J. M. W., Breedveld, F. C., & Huizinga, T. W. J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.010298 · Cited by 153
Pincus, T. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.12.1346 · Cited by 151
Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.
Çalgünerı, M., Pay, S., Çalışkaner, Z., Apras, S., Kiraz, S., Ertenli, İ., & Cobankara (1999) · PubMed · Cited by 132
Jones, G. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/keg036 · Cited by 131
O’Dell, J. R., Paulsen, G., Haire, C. E., Blakely, K., PALMER, W. R., Wees, S. J., Eckhoff, P. J., Klassen, L. W., Churchill, M. A., Doud, D. K., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1691::aid-anr18>3.0.co;2-s · Cited by 129
Munro, R., Hampson, R., McEntegart, A., Thomson, E. A., Madhok, R., & Capell, H. A. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.2.88 · Cited by 114
Verstappen, S. M. M., Jacobs, J. W. G., Bijlsma, J. W. J., Heurkens, A. H. M., van Booma-Frankfort, C., ter Borg, E. J., Hofman, D. M., & van der Veen, M. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11170 · Cited by 109
Hansen, M., Pødenphant, J., Florescu, A., et al. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.11.713 · Cited by 96
Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial
van Jaarsveld, C. H. M., Jacobs, J. W. G., Veen, M. J. V. D., Blaauw, A. A., Kruize, A. A., Hofman, D. M., Brus, H. L. M., van Albada-Kuipers, G. A., Heurkens, A. H. M., ter Borg, E. J., et al. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.6.468 · Cited by 90
Luukkainen, R., KAJANDER, A., & Isomäki, H. A. (1977) · Scandinavian Journal of Rheumatology · doi:10.3109/03009747709095448 · Cited by 86
Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up
van der Heijde, D. M. F. M., van Riel, P. L. C. M., Nuver-Zwart, I. H., & van de Putte, L. B. A. (1990) · The Lancet · doi:10.1016/0140-6736(90)90771-v · Cited by 76
Antirheumatic drugs: A proposed new classification
Edmonds, J. P., Scott, D. L., Furst, D. E., Brooks, P., & Paulus, H. E. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360308 · Cited by 71
Wax, S. D., Piecyk, M., Maritim, B., & Anderson, P. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10780 · Cited by 61
Rich, E., Moreland, L. W., & Alarcón, G. S. (1999) · PubMed · Cited by 53
Amjadi, S., Amjadi, S., Khanna, D., Park, G. S., Bulpitt, K. J., Wong, W. K., & Paulus, H. E. (2004) · PubMed · Cited by 41
van den Borne, B. E. E. M., Landewé, R., Thè, H. S. G., et al. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609104063 · Cited by 16
Cited by
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018) · Bone Research · doi:10.1038/s41413-018-0016-9 · Cited by 1,767
Black, R. J., Cross, M., Haile, L. M., Culbreth, G. T., Steinmetz, J. D., Hagins, H., Kopec, J. A., Brooks, P. M., Woolf, A. D., Ong, K. L., et al. (2023) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00211-4 · Cited by 674
van der Heijde, D., Tanaka, Y., Fleischmann, R., Keystone, E., Kremer, J., Zerbini, C., Cardiel, M. H., Cohen, S., Nash, P., Song, Y., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37816 · Cited by 577
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
Wang, W., Zhou, H., & Liu, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.027 · Cited by 562
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Singh, J. A., Christensen, R., Wells, G. A., Suarez-Almazor, M. E., Buchbinder, R., Lopez-Olivo, M. A., Ghogomu, E. T., & Tugwell, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007848.pub2 · Cited by 470
Metadata
- Authors
- Finckh, A., Liang, M. H., van Herckenrode, C. M., & de Pablo, P.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2006-11-30
- Volume
- 55
- Issue
- 6
- Pages
- 864-872
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W1967672301
- Cited by
- 492
- References
- 49
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.